The cell bank contains over 2.6 billion human cells, sufficient to meet the company's foreseeable clinical trial requirements. "Completing the production of clinical-grade cells using the previously published protocol is one of the final steps before starting our clinical program," said Ruslan Semechkin, Ph.D., ISCO's Chief Scientific Officer.
http://ift.tt/1D9lDSJ
http://ift.tt/1D9lDSJ
No comments:
Post a Comment